The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+ acute lymphoblastic leukemia (ALL).
 
Mala Kiran Talekar
No Relationships to Disclose
 
Shannon L. Maude
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
George E Hucks
No Relationships to Disclose
 
Laura S Motley
No Relationships to Disclose
 
Colleen Callahan
No Relationships to Disclose
 
Claire M White
No Relationships to Disclose
 
Diane Baniewicz
No Relationships to Disclose
 
David Maxwell Barrett
Travel, Accommodations, Expenses - Therakos
 
Susan R. Rheingold
Employment - Axovant Sciences (I)
Stock and Other Ownership Interests - Axovant Sciences (I); Endo Pharmaceuticals (I)
 
Simon F. Lacey
Research Funding - Novartis
 
Bruce L Levine
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc.
Honoraria - Novartis
Consulting or Advisory Role - GE Healthcare
Research Funding - Novartis; Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - intellectual property and patents in the field of cell and gene therapy
Travel, Accommodations, Expenses - GE Healthcare
 
Jan J. Melenhorst
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent related to the manufacturing of CART cells and biomarkers in CART cell therapy
 
David T. Teachey
Consulting or Advisory Role - Janssen
Research Funding - Novartis (Inst)
 
Carl H. June
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Celldex; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties
 
Stephan A. Grupp
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis